Your browser doesn't support javascript.
loading
Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection.
Choi, Seong-Ho; Park, Ji Young; Kweon, Oh Joo; Park, Joung Ha; Kim, Min-Chul; Lim, Yaeji; Chung, Jin-Won.
Affiliation
  • Choi SH; Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
  • Park JY; Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea.
  • Kweon OJ; Department of Laboratory Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
  • Park JH; Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
  • Kim MC; Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
  • Lim Y; Department of Applied Statistics, Chung-Ang University, Seoul, Korea.
  • Chung JW; Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea. drjwchung@cau.ac.kr.
J Korean Med Sci ; 38(20): e155, 2023 May 22.
Article in En | MEDLINE | ID: mdl-37218354
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Limits: Humans Language: En Journal: J Korean Med Sci Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Limits: Humans Language: En Journal: J Korean Med Sci Year: 2023 Document type: Article